Almac Diagnostic Services is a global precision medicine company specialising in biomarker-driven clinical trial solutions. From RNA/DNA testing and genomic assays to companion diagnostics and software tools like claraT, the company enables stratified medicine approaches that guide better treatment decisions.
Originally spun out from Queen’s University Belfast in 2002 under the name ArraDx, the company now operates as part of the Almac Group, with laboratories in Craigavon, Northern Ireland and Durham, North Carolina. It remains deeply embedded in the QUBIS innovation ecosystem, combining academic collaboration and industry expertise to deliver precision medicine solutions worldwide.
Core capabilities:
- Biomarker discovery and validation
- RNA/DNA clinical trial testing
- Companion diagnostics development
- AI-enabled bioinformatics (e.g. claraT platform)